Children with cancer spend a substantial amount of time in the hospital,1  which is tremendously burdensome for patients and their families.2,3  Time outside the hospital has been shown to improve health, social, and financial outcomes.4  In general pediatrics, race-ethnicity and socioeconomic status impact hospital admission patterns, likely reflecting differential exposures to adverse social determinants of health.5  Thus, we hypothesize sociodemographic factors will similarly impact inpatient utilization in pediatric oncology. The objective of this study is to identify characteristics of children newly diagnosed with cancer who have high inpatient utilization and describe their admission patterns.

Data were sourced from the Florida 2016 to 2019 State Inpatient Database (SID). The Florida SID is a limited deidentified dataset and, thus, exempt from review by an institutional review board. Inpatient admissions for children aged 0 to 21 years with a cancer diagnosis were identified (n = 2652 patients). Cancer diagnoses were identified by the Clinical Classification Software Refined algorithm.6  The first encounter date coded with cancer was used to approximate the date of diagnosis. Patients were followed for 1 year (n = 11 067 admissions). Admissions were divided into planned admissions for diagnosis and treatment and unplanned for all others. Children experiencing a high utilization (HU) of inpatient services were defined as those in the top decile of cumulative length of stay (cLOS) for unplanned admissions.

Multivariable logistic regression was used to identify factors associated with HU adjusted for sex, race, ethnicity, age, payer, cancer type, median income quartile by zip code, and metro/non-metro county of residence. Covariates were obtained from the initial SID admission record. Results were reported as adjusted odds ratios (aOR) with 95% confidence intervals (CI). The average cLOS, cumulative admissions, and number of admissions by month were plotted over time and stratified by patient utilization.

Descriptive statistics of the cohort are shown in Table 1. Figure 1A reveals characteristics associated with HU from multivariable regression. Patients with HU had higher odds of being Black (aOR 1.64 [95% CI 1.12–2.39]) than non-Hispanic White. Those with HU had lower odds of having Hodgkins’s lymphoma (aOR 0.24 [95% CI 0.10–0.50]), leukemia (aOR 0.56 [95% CI 0.38–0.82]), and non-central nervous system (CNS) solid tumors (aOR 0.55 [95% CI 0.38–0.80]) versus CNS tumors. Patients with HU represented 10% of our cohort but accounted for 24.9% of total admission days and 45.2% of unplanned admission days.

TABLE 1

Cohort Demographics

Overall, n = 2652High-Utilizers, n = 224Non-High-Utilizers, n = 2428
Age group, n (%) 
 0–14 1535 (57.9) 131 (58.5) 1404 (57.8) 
 15–21 1117 (42.1) 93 (41.5) 1024 (42.2) 
Sex, n (%)    
 Male 1457 (54.9) 127 (56.7) 1330 (54.8) 
 Female 1195 (45.1) 97 (43.3) 1098 (45.2) 
Race and Hispanic ethnicity, n (%) 
 Non-Hispanic White 1232 (46.5) 85 (37.9) 1147 (47.2) 
 Non-Hispanic Black 472 (17.8) 55 (24.6) 417 (17.2) 
 Hispanic 754 (28.4) 70 (31.2) 684 (28.2) 
 Non-Hispanic other 194 (7.3) 14 (6.2) 180 (7.4) 
Cancer type, n (%) 
 CNS 473 (17.8) 61 (27.2) 412 (17.0) 
 Hodgkin's lymphoma 200 (7.5) <11* <200* 
 Non-Hodgkin lymphoma 258 (9.7) <30* <240* 
 Leukemia 806 (30.4) 63 (28.1) 743 (30.6) 
 Solid tumor 915 (34.5) 70 (31.2) 845 (34.8) 
Payer status, n (%) 
 Private 1060 (40.0) 72 (32.1) 988 (40.7) 
 Public 1376 (51.9) 135 (60.3) 1241 (51.1) 
 Other 216 (8.1) 17 (7.6) 199 (8.2) 
Geographic area, n (%) 
 Metro 2517 (94.9) <224* <2300* 
 Nonmetro 135 (5.1) <11* <150* 
Median household income quartile of zip code, n (%) 
 Quartile 1 (lowest income) 758 (29.0) 71 (32.4) 687 (28.7) 
 Quartile 2 658 (25.2) 58 (26.5) 600 (25.1) 
 Quartile 3 661 (25.3) 55 (25.1) 606 (25.3) 
 Quartile 4 (highest income) 535 (20.5) 35 (16.0) 500 (20.9) 
Overall, n = 2652High-Utilizers, n = 224Non-High-Utilizers, n = 2428
Age group, n (%) 
 0–14 1535 (57.9) 131 (58.5) 1404 (57.8) 
 15–21 1117 (42.1) 93 (41.5) 1024 (42.2) 
Sex, n (%)    
 Male 1457 (54.9) 127 (56.7) 1330 (54.8) 
 Female 1195 (45.1) 97 (43.3) 1098 (45.2) 
Race and Hispanic ethnicity, n (%) 
 Non-Hispanic White 1232 (46.5) 85 (37.9) 1147 (47.2) 
 Non-Hispanic Black 472 (17.8) 55 (24.6) 417 (17.2) 
 Hispanic 754 (28.4) 70 (31.2) 684 (28.2) 
 Non-Hispanic other 194 (7.3) 14 (6.2) 180 (7.4) 
Cancer type, n (%) 
 CNS 473 (17.8) 61 (27.2) 412 (17.0) 
 Hodgkin's lymphoma 200 (7.5) <11* <200* 
 Non-Hodgkin lymphoma 258 (9.7) <30* <240* 
 Leukemia 806 (30.4) 63 (28.1) 743 (30.6) 
 Solid tumor 915 (34.5) 70 (31.2) 845 (34.8) 
Payer status, n (%) 
 Private 1060 (40.0) 72 (32.1) 988 (40.7) 
 Public 1376 (51.9) 135 (60.3) 1241 (51.1) 
 Other 216 (8.1) 17 (7.6) 199 (8.2) 
Geographic area, n (%) 
 Metro 2517 (94.9) <224* <2300* 
 Nonmetro 135 (5.1) <11* <150* 
Median household income quartile of zip code, n (%) 
 Quartile 1 (lowest income) 758 (29.0) 71 (32.4) 687 (28.7) 
 Quartile 2 658 (25.2) 58 (26.5) 600 (25.1) 
 Quartile 3 661 (25.3) 55 (25.1) 606 (25.3) 
 Quartile 4 (highest income) 535 (20.5) 35 (16.0) 500 (20.9) 
*

Indicates masked value due to small n.

FIGURE 1

Forest plot and admission patterns of children with high utilization. A, Forest plot of adjusted odds ratio for children with high utilization versus without. B, Average cumulative length of hospital stay in days over 1 year of follow-up time after cancer diagnosis. C, Average cumulative number of admissions over 1 year of follow-up time after cancer diagnosis. D, Average number admissions by month over 1 year of follow-up time after cancer diagnosis.

FIGURE 1

Forest plot and admission patterns of children with high utilization. A, Forest plot of adjusted odds ratio for children with high utilization versus without. B, Average cumulative length of hospital stay in days over 1 year of follow-up time after cancer diagnosis. C, Average cumulative number of admissions over 1 year of follow-up time after cancer diagnosis. D, Average number admissions by month over 1 year of follow-up time after cancer diagnosis.

Close modal

Examining admission patterns, the average cLOS of unplanned admissions steeply increased among patients with HU but remained nearly unchanged for those with non-HU (Fig 1B). The average cumulative number of unplanned admissions for patients with HU continually increased over time, whereas unplanned admissions for those with non-HU tapered off (Fig 1C). When admissions were averaged by month, all patients showed the most unplanned admissions occurring in the first 2 months (Fig 1D). However, patients with HU averaged more unplanned admissions at all time points. Importantly, planned admissions were also longer and more frequent in those with HU (Fig 1B–D).

We identified a group of newly diagnosed pediatric oncology patients with dramatically more and longer hospitalizations. These patients were more likely to be Black and have CNS tumors. Although hospitalizations for children with CNS tumors are likely related to their grim prognosis and need for complex surgical resection,7  excess hospitalizations among Black children is disconcerting for structural racism, resulting in a lack of outpatient support, toxic stress, material hardship, delays in presentation to care, and discrimination.5,8 

Our results must be considered with the following limitations. First, a reliance on billing codes to identify our study population and outcome may lead to underreporting the true number of patients diagnosed with cancer, as well as properly classifying unplanned admissions. Second, using the first reported hospital admission with a cancer diagnosis is only an approximation of the cancer date of diagnosis. Third, we were unable to control for potential confounders, such as disease severity at diagnosis and cancer subtype and staging, that influence care and treatment plans.

Despite these limitations, our findings generate critical hypotheses as to whether Black children are differentially burdened by inpatient admissions. Hospitalizations increase the risk for medical complications such as nosocomial infections and thromboembolism,9  as well as nonmedical complications, such as loss of employment, divorce/separation, and psychological distress.2,4  Future efforts are needed to determine the underlying cause of differential utilization and provide targeted support to improve quality care.

Dr Shoag conceptualized and designed the study and drafted the initial manuscript; Mr Vu designed the data analysis plan, collected data, and conducted the initial analyses; Dr Cullen conceptualized the study and advised on interpretation of study results; Dr Koroukian conceptualized and designed the study and coordinated and supervised data collection; and all authors critically reviewed and revised the manuscript, approved the final manuscript as submitted, and agree to be accountable for all aspects of the work.

FUNDING: Mr Vu, Dr Cullen, and Dr Koroukian are supported by the Case Comprehensive Cancer Center (P30 CA043703).

CONFLICT OF INTEREST DISCLOSURES: The authors have indicated they have no potential conflicts of interest relevant to this article to disclose.

1
Price
RA
,
Stranges
E
,
Elixhauser
A
.
Pediatric Cancer Hospitalizations, 2009
. In:
Statistical Brief #132. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs
.
Agency for Healthcare Research and Quality (US)
;
2006
2
Lau
S
,
Lu
X
,
Balsamo
L
, et al
.
Family life events in the first year of acute lymphoblastic leukemia therapy: a children’s oncology group report
.
Pediatr Blood Cancer
.
2014
;
61
(
12
):
2277
2284
3
Warner
EL
,
Kirchhoff
AC
,
Nam
GE
,
Fluchel
M
.
Financial burden of pediatric cancer for patients and their families
.
J Oncol Pract
.
2015
;
11
(
1
):
12
18
4
Jibb
LA
,
Chartrand
J
,
Masama
T
,
Johnston
DL
.
Home-based pediatric cancer care: perspectives and improvement suggestions from children, family caregivers, and clinicians
.
JCO Oncol Pract
.
2021
;
17
(
6
):
e827
e839
5
McKay
S
,
Parente
V
.
Health disparities in the hospitalized child
.
Hosp Pediatr
.
2019
;
9
(
5
):
317
325
6
Agency for Healthcare Research and Quality
. Clinical classifications software refined (CCSR). Available at: https://hcup-us.ahrq.gov/toolssoftware/ccsr/ccs_refined.jsp. Accessed February 16, 2023
7
Ostrom
QT
,
Price
M
,
Neff
C
, et al
.
CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015–2019
.
Neuro-oncol
.
2022
;
24
(
Suppl 5
):
v1
v95
8
Cooper
RS
,
Nadkarni
GN
,
Ogedegbe
G
.
Race, ancestry, and reporting in medical journals
.
JAMA
.
2018
;
320
(
15
):
1531
1532
9
Villanueva
MA
,
August
KJ
.
Early discharge of neutropenic pediatric oncology patients admitted with fever
.
Pediatr Blood Cancer
.
2016
;
63
(
10
):
1829
1833